SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001169232-05-004045
Filing Date
2005-08-11
Accepted
2005-08-11 08:52:10
Documents
5
Period of Report
2005-08-08
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT d64877_8-k.htm 8-K 17995
2 CONVERTIBLE NOTE d64877_ex4-1.htm EX-4.1 87742
3 SUBSCRIPTION AGREEMENT d64877_ex10-1.htm EX-10.1 62808
4 PRESS RELEASE d64877_ex99-1.htm EX-99.1 7791
5 GRAPHIC img1.jpg GRAPHIC 3899
  Complete submission text file 0001169232-05-004045.txt   183592
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50590 | Film No.: 051015157
SIC: 2834 Pharmaceutical Preparations